crta
Hrvatska znanstvena Sekcija img
bibliografija
3 gif
 Naslovna
 O projektu
 FAQ
 Kontakt
4 gif
Pregledavanje radova
Jednostavno pretraživanje
Napredno pretraživanje
Skupni podaci
Upis novih radova
Upute
Ispravci prijavljenih radova
Ostale bibliografije
Slični projekti
 Bibliografske baze podataka

Pregled bibliografske jedinice broj: 37170

Zbornik radova

Autori: Kapitanović, Sanja; Radošević, Senka; Ferenčić, Željko; Spaventi, Šime; Pavelić, Krešimir; Spaventi, Radan
Naslov: Expression of the erbB family in colorectal adenocarcinoma
Izvornik: European Journal of Cancer (Supplement)(ECCO 10 abstract book)Beč :
Skup: The European Cancer Conference ECCO 10
Mjesto i datum: Beč, Austrija, 12.-16.09.1999.
Ključne riječi: oncogene; erbB family; colorectal adenocarcinoma
Sažetak:
Purpose: The most frequently implicated receptors in human cancers are members of the EGF receptor (erbB) subfamily. In addition to EGFR, it includes erbB-2, erbB-3, and the recently discovered erbB-4. Transforming activity of different erbB genes by overexpression have been observed in a variety of tumors. Gene amplification and/or an icrease in transcription are the most common cause of erbB protein overexpression in tumors. The present study investigates expression of the different erbB proteins in colon cancers and its correlation with patient's survival. Methods: The expression of erbB proteins was examined by immunohistochemistry using specific antibody and immunoperoxidase reaction. The results were analyzed semiquantitatively and correlated with patient's survival. Results: In the present study we found expresion of the EGFR and erbB-2 protein in all tumor specimens investigated. The erbB-3 protein was expressed in 78% colorectal adenocarcinomas. EGFR was overexpressed in 51% of colorectal adenocarcinomas, but there was no correlation between EGFR overexpresion and patient's survival. The level of erbB-2 protein varies between tumors and elevated expression correlates strongly with survival (p<0.001). The patients with tumors that were immunohistochemicaly positive to erbB-3 protein had significantly shorter survival (p<0.01). In a multivariante analysis of clinico-pathological factors and erbB proteins expression, age, Dukes' stage, erbB-2 and erbB-3 protein were found to be independent prognostic markers. Conclusion: This findings indicate that assessement of erbB-2 and erbB-3 overexpression can be useful indicator in prognosis of colorectal adenocarcinoma.
Vrsta sudjelovanja: Poster
Vrsta prezentacije u zborniku: Sažetak
Vrsta recenzije: Međunarodna recenzija
Projekt / tema: 00981104, 101751
Izvorni jezik: ENG
Kategorija: Znanstveni
Znanstvena područja:
Temeljne medicinske znanosti



  Verzija za printanje   za tiskati


upomoc
foot_4